Long-Acting FC-fusion rhGH (GX-H9) Shows Potential for Up to Twice-Monthly Administration in GH-deficient Adults

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-18-0185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Lipoatrophy in GH Deficient Patients Treated With a Long-Acting Pegylated GH

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2009English

Abnormal Metabolic Phenotype in Middle-Aged GH-deficient Adults Despite Long-Term Recombinant Human GH Replacement

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2014English

Final Height (Fh) and Satisfaction in Gh Deficient Adults Who Were Treated With Gh in Childhood

Pediatric Research
Child HealthPediatricsPerinatology
1993English

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity After a Single Administration

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Chaperones Team Up Twice

Journal of Cell Biology
MedicineCell Biology
2012English

GH Replacement Therapy in Elderly GH-deficient Patients: A Systematic Review

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2011English

Relationship Between Zinc and Growth Hormone (GH) in GH Deficient Children

Pediatric Research
Child HealthPediatricsPerinatology
1981English

Association ofCOLIA1 Sp1polymorphism With the Effect of Subcutaneously Injected Recombinant hGH in GH-deficient Adults

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2008English

Update on GH Therapy in Adults

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy